Aurobindo Pharma
BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01029 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Mar 2008 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Drugs Bulk & Intermediates | Metric Tonnes | 15,344 | 8,706.00 | 5,442.28 | 1,452.32 |
| Formulation Capsules/Tablets | Lakhs Numbers | 88,112 | 33,208.00 | 33,037.00 | 774.06 |
| Other Operating Income | - | NA | NA | NA | 57.20 |
| Injections | - | NA | NA | 16,299,209.00 | 37.60 |
| Syrups | Numbers | 47,800,000 | 4,604,674.00 | 4,337,033.00 | 29.94 |
| Injectables | Numbers | 55,980,000 | 18,653,627.00 | NA | 0.00 |
| Others | - | NA | NA | NA | 0.00 |
| Total | 2,351.12 | ||||
![]() | |||||
| Source : Religare Technova | |||||
![]() | |||||




Online










